NL7712154A - Verbeterde werkwijze ter bereiding van metho- trexate. - Google Patents

Verbeterde werkwijze ter bereiding van metho- trexate.

Info

Publication number
NL7712154A
NL7712154A NL7712154A NL7712154A NL7712154A NL 7712154 A NL7712154 A NL 7712154A NL 7712154 A NL7712154 A NL 7712154A NL 7712154 A NL7712154 A NL 7712154A NL 7712154 A NL7712154 A NL 7712154A
Authority
NL
Netherlands
Prior art keywords
methotrexate
preparation
improved procedure
procedure
improved
Prior art date
Application number
NL7712154A
Other languages
English (en)
Dutch (nl)
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of NL7712154A publication Critical patent/NL7712154A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes
    • C07F9/5355Phosphoranes containing the structure P=N-
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NL7712154A 1976-11-17 1977-11-03 Verbeterde werkwijze ter bereiding van metho- trexate. NL7712154A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,450 US4080325A (en) 1976-11-17 1976-11-17 Synthesis of methotrexate

Publications (1)

Publication Number Publication Date
NL7712154A true NL7712154A (nl) 1978-05-19

Family

ID=24984894

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7712154A NL7712154A (nl) 1976-11-17 1977-11-03 Verbeterde werkwijze ter bereiding van metho- trexate.

Country Status (11)

Country Link
US (1) US4080325A (fr)
JP (1) JPS5398996A (fr)
AU (1) AU511019B2 (fr)
CA (1) CA1077477A (fr)
DE (1) DE2741270A1 (fr)
FR (1) FR2371446A1 (fr)
GB (3) GB1595337A (fr)
IL (1) IL53164A (fr)
NL (1) NL7712154A (fr)
RO (1) RO75303A (fr)
SU (1) SU738511A3 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306064A (en) * 1980-03-25 1981-12-15 Ellard James A Synthesis of 2,4-diamino-6-hydroxymethylpteridine
US4421913A (en) * 1980-04-23 1983-12-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Separation of triphenylphosphine oxide from methotrexate ester and purification of said ester
DE4309123C2 (de) * 1993-03-22 1998-07-02 Mack Chem Pharm Verfahren zur Herstellung von 2,4-Diamino-6-(hydroxymethyl)pteridin-Salzen
US5382582A (en) * 1993-03-26 1995-01-17 Chan; Carcy L. Methotrexate analogs and methods of using same
DE19503966C2 (de) * 1995-02-07 1998-07-02 Mack Chem Pharm Kristallmodifikation von 2,4-Diamino-6-hydroxymethylpteridin-Hydrobromid, Verfahren zu dessen Herstellung und dessen Verwendung
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
GB9617727D0 (en) 1996-08-23 1996-10-02 Knoll Ag Process
WO1998024477A1 (fr) 1996-12-06 1998-06-11 Amgen Inc. Therapie combinee utilisant un inhibiteur de l'il-1 pour traiter les maladies induites par l'il-1
GB9626746D0 (en) * 1996-12-23 1997-02-12 Knoll Ag Process
DE19904812A1 (de) * 1999-02-05 2000-08-10 Basf Ag Verfahren zur Herstellung von Folsäure
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
WO2004060911A2 (fr) * 2002-12-30 2004-07-22 Amgen Inc. Polytherapie a facteurs costimulants
US6921667B2 (en) 2003-03-07 2005-07-26 Prometheus Laboratories, Inc. Methods for direct detection of individual methotrexate metabolites
US7582282B2 (en) 2003-08-29 2009-09-01 Prometheus Laboratories Inc. Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
WO2006031614A2 (fr) * 2004-09-10 2006-03-23 Tosk, Inc. Formulations de methotrexate a toxicite reduite et methodes d'utilisation associees
US20060286571A1 (en) 2005-04-28 2006-12-21 Prometheus Laboratories, Inc. Methods of predicting methotrexate efficacy and toxicity
US20070123478A1 (en) 2005-11-28 2007-05-31 Rowe Vernon D Compositions useful for reducing nephrotoxicity and methods of use thereof
US7998967B2 (en) 2008-03-03 2011-08-16 Tosk, Incorporated Methotrexate adjuvants to reduce toxicity and methods for using the same
JP5732039B2 (ja) 2009-03-20 2015-06-10 アンタレス・ファーマ・インコーポレーテッド 危険有害性薬剤の注入システム
WO2012037068A1 (fr) 2010-09-13 2012-03-22 De Novo Diagnostics, Inc. Méthodes de surveillance de thérapie par méthotrexate
JP5785622B2 (ja) * 2010-12-03 2015-09-30 コチャク ファルマ イラチュ ヴェキミャ サン.アー.シェーKocak Farma Ilac Ve Kimya San.A.S その構造内にグルタミン酸部分を有する葉酸拮抗薬の新規な製造方法
US20140135337A1 (en) 2011-05-16 2014-05-15 Genzyme Corporation Induction of immune tolerance by using methotrexate
CA2911041C (fr) 2012-05-01 2020-12-15 Shelley Romayne BOYD Procede de traitement et de diagnostic de maladies menant a la cecite
CN102952137A (zh) * 2012-10-08 2013-03-06 天津科创医药中间体技术生产力促进有限公司 一种2,4-二氨基-6-溴甲基蝶啶的制备方法
AU2015371308A1 (en) 2014-12-23 2017-08-03 Intellectual Property Associates, Llc Methods and formulations for transdermal administration
CN107698592A (zh) * 2016-08-09 2018-02-16 浙江海正药业股份有限公司 一种甲氨蝶呤盐的纯化工艺
US20190083386A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents
CN113461689B (zh) * 2021-06-30 2023-03-31 浙江浙北药业有限公司 一种甲氨蝶呤化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989703A (en) * 1974-03-22 1976-11-02 Institutul Oncologic Process of preparing N[p-{[(2,4-diamino-6-pteridyl)-methyl]N10 -methylamino}-benzoyl]-glutamic acid
FR2270245A1 (en) * 1974-03-26 1975-12-05 Inst Oncologic Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid

Also Published As

Publication number Publication date
IL53164A0 (en) 1977-12-30
US4080325A (en) 1978-03-21
RO75303A (fr) 1980-11-30
AU511019B2 (en) 1980-07-24
IL53164A (en) 1980-06-30
SU738511A3 (ru) 1980-05-30
DE2741270A1 (de) 1978-05-18
GB1595102A (en) 1981-08-05
CA1077477A (fr) 1980-05-13
GB1595337A (en) 1981-08-12
GB1595338A (en) 1981-08-12
AU3039377A (en) 1979-05-17
JPS5398996A (en) 1978-08-29
FR2371446A1 (fr) 1978-06-16

Similar Documents

Publication Publication Date Title
NL7712154A (nl) Verbeterde werkwijze ter bereiding van metho- trexate.
NL7709025A (nl) Werkwijze ter bereiding van allergeenhoudende stof- fen.
NL7706914A (nl) Werkwijze ter bereiding van hardbare mengsels.
NL7708511A (nl) Verbeterde werkwijze voor de bereiding van kool- waterstoffen.
NL183033C (nl) Werkwijze voor de bereiding van n-fosfonomethylglycine.
NL7707421A (nl) Werkwijze ter bereiding van roentgenstraal- contrastmiddelen.
NL7702957A (nl) Werkwijze ter bereiding van stikstofhoudende verbindingen.
NL7711358A (nl) Werkwijze voor de bereiding van spiro-hydantoine- verbindingen.
NL178684C (nl) Werkwijze voor de bereiding van dialkyloxalaten.
NL7708811A (nl) Werkwijze voor de bereiding van 2-hydroxyben- zoezuuraldehyden.
NL7703892A (nl) Werkwijze voor de bereiding van maleineimiden.
NL7701333A (nl) Werkwijze ter bereiding van wasmiddelen.
NL7702420A (nl) Werkwijze voor de bereiding van formamiden.
NL7709055A (nl) Werkwijze ter bereiding van 3-chloorcefalosporine- derivaten.
NL7713053A (nl) Werkwijze ter bereiding van waspoeders.
NL189129C (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7708613A (nl) Werkwijze ter bereiding van wrongel.
NL7700908A (nl) Werkwijze ter bereiding van faujasiet.
NL189088C (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7705086A (nl) Werkwijze ter bereiding van smeltplakmiddelen.
NL7707767A (nl) Werkwijze voor de bereiding van gesubstitueer- de benzaldehyden.
NL7707729A (nl) Werkwijze voor de bereiding van 5-m-tolyloxy- uracil.
NL7707229A (nl) Werkwijze voor de bereiding van methyldichloor- fosfaan.
NL188996C (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7707763A (nl) Werkwijze voor de bereiding van methyldichloor- fosfaan.

Legal Events

Date Code Title Description
BV The patent application has lapsed